How Did the COVID-19 Lockdown Pandemic Affect the Depression Symptomatology in Mediterranean Older Adults with Metabolic Syndrome?

• Published in: Depression and anxiety 2023-07, Vol.2023, p.1-9
• Main Authors: Paz-Graniel, Indira, Babio, Nancy, Nishi, Stephanie K., Martínez-González, Miguel Ángel, Corella, Dolores, Fitó, Montserrat, Martínez, Alfredo, Alonso-Gómez, Ángel M., Wärnberg, Julia, Vioque, Jesús, Romaguera, Dora, López-Miranda, José, Estruch, Ramon, Tinahones, Francisco J., Santos-Lozano, José Manuel, Serra-Majem, J. Luís, Bueno-Cavanillas, Aurora, Tur, Josep A., Sánchez, Vicente Martín, Pintó, Xavier, Delgado-Rodríguez, Miguel, Matía-Martín, Pilar, Vidal, Josep, Calderon-Sanchez, Cristina, Daimiel, Lidia, Ros, Emili, Fernández-Aranda, Fernando, Toledo, Estefania, Valle-Hita, Cristina, Sorli, Jose V., Lassale, Camille, Garcia-Rios, Antonio, Oncina-Canovas, Alejandro, Barón-López, Francisco Javier, Zulet, M. Angeles, Rayó, Elena, Casas, Rosa, Thomas-Carazo, Esther, Tojal-Sierra, Lucas, Damas-Fuentes, Miguel, Ruiz-Canela, Miguel, De las Heras-Delgado, Sara, Fernandez-Carrión, Rebeca, Castañer, Olga, Peña-Orihuela, Patricia J., Gonzalez-Palacios, Sandra, Buil-Cosiales, Pilar, Goday, Albert, Salas-Salvadó, Jordi
• Format: Article
• Language: English
• ISSN: 1091-4269; 1520-6394
• DOI: 10.1155/2023/6765950

Background and Aims. To control the COVID-19 spread, in March 2020, a forced home lockdown was established in Spain. In the present study, we aimed to assess the effect of mobility and social COVID-19-established restrictions on depressive symptomatology in older adults with metabolic syndrome. We hypothesize that severe restrictions might have resulted in detrimental changes in depressive symptomatology. Methods. 2,312 PREDIMED-Plus study participants (men=53.9%; mean age=64.9±4.8 years) who completed a COVID-19 lockdown questionnaire to assess the severity of restrictions/lockdown and the validated Spanish version of the Beck Depression Inventory-II (BDI-II) during the three established phases concerning the COVID-19 lockdown in Spain (prelockdown, lockdown, and postlockdown) were included in this longitudinal analysis. Participants were categorized according to high or low lockdown severity. Analyses of covariance were performed to assess changes in depressive symptomatology across lockdown phases. Results. No significant differences in participant depression symptomatology changes were observed between lockdown severity categories (low/high) at the studied phases. During the lockdown phase, participants showed a decrease in BDI-II score compared to the prelockdown phase (mean (95% CI), -0.48 (-0.24, -0.72), P